FIELD: chemistry.
SUBSTANCE: described are novel compounds of general formula ,
where X equals 1 or 2; Y equals 0 1, 2, or 3; R1 is hydrogen, C1-2alkyl or C1-2alkoxy; A denotes 2,6,-dimethylphenyl, a pharmaceutical composition containing same, a method of reducing concentration of uric acid in blood or increasing release of uric acid in a mammalian subject, and use the novel compounds to obtain a medicinal agent for treating, particularly, gout and hyperuricemia.
EFFECT: obtaining a medicinal agent for treating gout and hyperuricemia.
30 cl, 9 dwg, 17 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501554C2 |
COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501555C2 |
COMPOUND FOR TREATING METABOLIC DISORDERS | 2008 |
|
RU2521284C2 |
COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
COMPOUNDS FOR TREATING METABOLIC DISEASES | 2008 |
|
RU2502723C2 |
COMPOUNDS FOR TREATMENT OF METABOLIC DISEASES | 2002 |
|
RU2341513C2 |
CRYSTAL OF AZOLE BENZENE DERIVATIVE | 2015 |
|
RU2675854C2 |
COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2358722C2 |
AZOLE DERIVATIVES OF BENZENE | 2014 |
|
RU2641891C2 |
AZOBENZENE DERIVATIVE AND CRYSTALLINE FORM THEREOF | 2015 |
|
RU2701515C2 |
Authors
Dates
2014-07-10—Published
2009-04-30—Filed